GnRH-a联合LNG-IUS对子宫腺肌症患者血清CA125 VEGF FSH LH的影响

doi:10.3969/j.issn.1006-6233.2018.10.008

Abstract
Figure/Table
References
Related Citation (0)

Download: PDF (1269 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To study curative efficacy of GnRH-a combined with LNG-IUS in treatment of uterine adenomyosis and its effects on level of CA125,VEGF,FSH and LH. Methods: 60 patients of uterine adenomyosis who received therapy from June 2015 to June 2017 in our hospital were selected as research objects. According to the different treatment plan divided into observation group and control group, the control group to hysterectomy, the observation group given GnRH-a combined with LNG-IUS treatment. The levels of serum CA125, VEGF, FSH and LH were measured before and after treatment, and the dysmenorrhea, uterine volume and menstrual flow were observed. Results: After treatment, the total effective rate (90.0%) in the observation group was significantly higher than that in the control group (73.3%) (P<0.05). The levels of serum CA125, VEGF, FSH and LH were significantly lower than those in the control group (P<0.05). The incidence of dyspepsia in the observation group was significantly lower than that in the control group (P<0.05). The incidence of adverse reactions in the observation group was significantly lower than that in the control group (P<0.05) The reaction rate was 26.7%, and the difference was significant (P<0.05). Conclusion: Shenfu injection unite recombinant human brain natriuretic peptide treatment of patients with chronic heart failure can effectively improve on cardiac function, the BNP, mmp-9, CypA levels were to reduce, significantly improve the clinical curative effect, and can reduce adverse reaction. GnRH-a combined with LNG-IUS treatment of patients with AM, effectively reduce serum CA125, VEGF, FSH and LH levels and reduce dysmenorrhea rating, uterine volume and menstrual score, and can reduce adverse reactions.

Key words： GnRH-a LNG-IUS Uterine adenomyosis CA125

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	QI Jin
	DENG Xiaohong

Cite this article:

QI Jin,DENG Xiaohong. Effect of GnRH-a combined with LNG-IUS on Serum CA125 VEGF FSH and LH in Patients with Adenomyosis[J]. HeBei Med, 2018, 24(10): 1615-1618.

URL:

http://www.hbyxzzs.cn/EN/10.3969/j.issn.1006-6233.2018.10.008 OR http://www.hbyxzzs.cn/EN/Y2018/V24/I10/1615

[1] 赵颖.GnRH-a联合LNG-IUS治疗子宫腺肌症的效果观察[J].中国妇幼保健,2017,32(6):1194~1196.
[2] 李盛,严浩.LNG-IUS联合TCRE治疗对子宫腺肌症患者卵巢功能、MMP指标及相关因子水平的影响[J].海南医学院学报,2017,23(23):3251~3254.
[3] 麦艳芬,钱怀萍,周瑞芳,等.性腺激素释放激素激动剂联合戊酸雌二醇对重度子宫内膜异位症患者血清CA125、VEGF水平及远期复发的影响[J].中国计划生育和妇产科,2017,9(2):75~78.
[4] 季菲,何艳,丁岩.左炔诺孕酮宫内节育系统对子宫腺肌病疼痛及对卵巢功能的影响[J].新疆医学,2016,46(8):919~922.
[5] 张娅,肖雁冰.GnRH-a联合LNG-IUS与LNG-IUS治疗子宫腺肌病的短期疗效观察[J].中国现代医生,2016,54(19):63~66.
[6] 关秀君,孙大伟.左炔诺孕酮宫内缓释系统在子宫腺肌症中的应用[J].中国妇幼保健,2016,31(19):3915~3916.
[7] 印慧琴.腹腔镜下卵巢子宫内膜异位囊肿剥除术联合GnRH-a对子宫内膜异位囊肿患者FSH、LH、E2的影响[J].中国妇幼保健,2017,32(18):4589~4591.
[8] 涂皎,高毅,黄茂兰,等.左炔诺孕酮宫内缓释系统对子宫腺肌症患者月经及卵巢功能的影响研究[J].中国全科医学,2016(4):427~430.
[9] 刘倩芬.治疗性左炔诺孕酮宫内缓释系统对经量过多和痛经的疗效观察[D].重庆医科大学,2016.
[10] 王艳芬.左炔诺孕酮宫内节育系统联合GnRh-α口服避孕药对子宫腺肌症的影响[J].山西医药杂志,2016,45(4):434~436.
[11] 马宏龙.腹腔镜切除病灶联合曼月乐治疗子宫腺肌症的效果及对卵巢功能的影响[J].中国妇幼保健,2017,32(18).
[12] 赵成,赵卫东,周虎,等.高强度聚焦超声联合GnRH-a治疗子宫腺肌症的临床研究[J].安徽医科大学学报,2017(12):1839~1844.
[13] 高芳丹.贝依联合曼月乐治疗子宫腺肌症的疗效观察及对患者月经的影响[J].国际医药卫生导报,2016,22(1):59~61.
[14] 孟建辉.腹腔镜子宫腺肌症病灶切除术后联合GnRH-a治疗子宫腺肌症疗效观察[J].医药论坛杂志,2016(4):135~137.